Ethylcyclohexane is a cyclic alkane with the molecular formula C8H16. It is a colorless liquid with a gasoline-like odor. It is primarily used as a solvent, although it has also been used as a fuel additive and in the production of plastics. Ethylcyclohexane is synthesized through the hydrogenation of ethylbenzene, which is a process that adds hydrogen atoms to a molecule. The process typically involves the use of a catalyst such as nickel or platinum. Ethylcyclohexane is also produced as a byproduct of the petroleum refining process. Ethylcyclohexane is not known to have any significant biological effects. It is relatively inert and non-toxic. However, it is flammable and should be handled with care. Ethylcyclohexane is studied as a model compound for understanding the properties of cyclic alkanes. Its structure and properties are well-characterized, making it a useful tool for research. It is also studied as a potential fuel additive due to its high energy content and relatively low cost. Ethylcyclohexane is a relatively common compound and is not considered to be a significant environmental concern. It is biodegradable and does not persist in the environment.'
| ID Source | ID |
|---|---|
| PubMed CID | 15504 |
| CHEMBL ID | 1882821 |
| CHEBI ID | 137775 |
| MeSH ID | M0097212 |
| Synonym |
|---|
| LS-13496 |
| inchi=1/c8h16/c1-2-8-6-4-3-5-7-8/h8h,2-7h2,1h |
| einecs 216-835-0 |
| ethyl cyclohexane |
| ai3-15348 |
| nsc 8880 |
| ethylcyclohexane |
| wln: l6tj a2 |
| 1678-91-7 |
| nsc8880 |
| nsc-8880 |
| cyclohexane, ethyl- |
| ethylcyclohexane, >=99% |
| NCGC00166032-01 |
| CHEBI:137775 |
| E0073 |
| A810916 |
| ethyl-cyclohexane |
| QSPL 100 |
| 567iji1215 , |
| unii-567iji1215 |
| LMFA11000659 |
| FT-0626176 |
| AKOS015906531 |
| cyclohexylethane |
| swaclean ech |
| 1-ethyl-cyclohexanecarbaldehyde |
| tox21_303745 |
| dtxcid4030334 |
| NCGC00357050-01 |
| dtxsid1051779 , |
| cas-1678-91-7 |
| CHEMBL1882821 |
| IIEWJVIFRVWJOD-UHFFFAOYSA-N |
| J-521341 |
| mfcd00001523 |
| J-010406 |
| Q21024279 |
| Class | Description |
|---|---|
| cycloalkane | Saturated monocyclic hydrocarbons (with or without side chains). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 7.6959 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 18.8876 | 0.0316 | 22.3146 | 100.0000 | AID588579 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (53.75) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||